Plaque, the nearly invisible evil that lives in everyone’s mouth, is responsible for so much of the possible damage to oral health that fighting it is dentristy’s most common battle. But Plaque HD toothpaste was developed in 2009 by an orthodontist who wanted to create a safe and at-home plaque-reduction program for people to use. It’s a toothpaste that utilizes Targetol Technology, a gluten-free coloring agent.
With this, the plaque on the teeth will be highlighted, and it will, in turn, be easier to clean the teeth and gums. However, according to randomized trials, it is believed that Plaque HD can also reduce inflammation throughout the body.

Testing the Theory
For years, many researchers have suggested that there could be a link between oral health and some inflammatory diseases which can affect the body. This includes heart attacks and strokes. High-sensitivity C-reactive proteins (hs-CRP) are how inflammation is measured in the body. It is also how doctors can predict potential future heart attacks and strokes.
In the trial, every participant was given the same brushing protocol. The hs-CRP levels were measured by using enzyme-linked immunosorbent assay. The findings revealed that Plaque HD toothpaste significantly reduces hs-CRP.
American Adults Often Have Some Inflammation

The United States Center for Disease Control and Prevention was able to find that 47.2% of all American adults 30 years old and older have some kind of periodontal disease. This is a condition that causes inflammation in the gyms and tissues around the teeth. The disease can increase with age, and it affects more than 70% of the adults in the country aged 65 years and older. Studies in the past have suggested that periodontal disease can be connected to other diseases, including heart disease and stroke, along with other diseases caused by inflammation.
Further testing will be done to see whether the reduction of inflammation in the body when using Plaque HD toothpaste can decrease the progression of atherosclerosis in areas of the heart.
Starbucks Has Chosen John Culver to Be Its Chief Operating Officer
Recently, Starbucks announced that the company veteran John Culver will become its new chief operating officer. Culver has been working for the company since 2002 and will now succeed Roz Brewer, who was the COO until February this year. Brewer is now CEO of Walgreens Boots Alliance.
John Culver Is Also the New North American Group President for Starbucks
After Roz Brewer exited Starbucks in February and went on to become a chief executive at Walgreens Boots Alliance, the company had to name a new COO. They finally chose Culver to succeed the former chief operating officer and also promoted him to North American group president.
Before he received the promotion, Culver was the group president for Starbucks international, channel development, and global coffee, tea, and cocoa. This role had him oversee the company’s cafes across 58 international markets, as well as its consumer packaged goods products. In addition to being with Starbucks for almost two decades, he also serves on the boards of Kimberly-Clark and Columbia Sportswear.
The CEO of Starbucks, Kevin Johnson, Made a Statement Regarding the Future of the Company
In a recent statement, Starbucks’ CEO Kevin Johnson said that as they plan for 2022 and beyond, they are fortunate to have talented and diverse senior executives. According to him, this gave the company the ability to tap into the great potential of experts who can lead them forward.
There were also other related promotions at Starbucks. Michael Conway will take over as the group president of international and channel development. He is currently working as the president of international licensed markets. Also, Michelle Burns, who is now the senior vice president of coffee and tea, will become the new executive vice president of global coffee, tea, and cocoa.
All the new Starbucks promotions are set to go into effect on June 28. Meanwhile, Starbucks’ shares have gone up 4% this year, and this means that the current market value of the company stands at $132 billion.